Primary peptide: KPV at 200 to 400 mcg subcutaneously daily Support peptide: Thymosin alpha-1 at 1.6 mg subcutaneously twice weekly Implementation schedule: Pre-season (4 weeks before): Begin KPV daily and Ta1 twice weekly to stabilize mast cells and rebalance Th1/Th2 ratio before allergen exposure peaks During season: Continue both peptides at the same doses throughout the allergy season Post-season: Taper KPV over 2 weeks
The key is ensuring mechanisms dont overlap redundantlystacking two AMPK activators, for example, provides diminishing returns
doi:10.1016/j.mehy.2021.110736 [3] Veljaca M., Sladoljev D., Mildner B
This product is not a drug, food, or cosmetic and may not be misbranded, misused or mis-labled as a drug, food or cosmetic
ResearchGate - Pentadecapeptide BPC 157 and the central nervous system: Reviews neuroprotective effects, brain-gut axis, and neurotransmitter modulation